237 related articles for article (PubMed ID: 30393214)
1. Cyclodextrin-based nanosponge for improvement of solubility and oral bioavailability of Ellagic acid.
Mady FM; Ibrahim SR
Pak J Pharm Sci; 2018 Sep; 31(5(Supplementary)):2069-2076. PubMed ID: 30393214
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evaluation of cyclodextrin-based nanosponges for enhancing oral bioavailability of atorvastatin calcium.
Zidan MF; Ibrahim HM; Afouna MI; Ibrahim EA
Drug Dev Ind Pharm; 2018 Aug; 44(8):1243-1253. PubMed ID: 29452493
[TBL] [Abstract][Full Text] [Related]
3. Investigation of Cyclodextrin-Based Nanosponges for Solubility and Bioavailability Enhancement of Rilpivirine.
Rao MRP; Chaudhari J; Trotta F; Caldera F
AAPS PharmSciTech; 2018 Jul; 19(5):2358-2369. PubMed ID: 29869305
[TBL] [Abstract][Full Text] [Related]
4. Enhanced anticancer activity and oral bioavailability of ellagic acid through encapsulation in biodegradable polymeric nanoparticles.
Mady FM; Shaker MA
Int J Nanomedicine; 2017; 12():7405-7417. PubMed ID: 29066891
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of solubility enhancement, antioxidant activity, and cytotoxicity studies of kynurenic acid loaded cyclodextrin nanosponge.
Dhakar NK; Caldera F; Bessone F; Cecone C; Pedrazzo AR; Cavalli R; Dianzani C; Trotta F
Carbohydr Polym; 2019 Nov; 224():115168. PubMed ID: 31472867
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of micronized ellagic acid using antisolvent precipitation for oral delivery.
Li Y; Zhao X; Zu Y; Zhang Y; Ge Y; Zhong C; Wu W
Int J Pharm; 2015; 486(1-2):207-16. PubMed ID: 25841566
[TBL] [Abstract][Full Text] [Related]
7. Potential of erlotinib cyclodextrin nanosponge complex to enhance solubility, dissolution rate, in vitro cytotoxicity and oral bioavailability.
Dora CP; Trotta F; Kushwah V; Devasari N; Singh C; Suresh S; Jain S
Carbohydr Polym; 2016 Feb; 137():339-349. PubMed ID: 26686138
[TBL] [Abstract][Full Text] [Related]
8. Ester-Based Hydrophilic Cyclodextrin Nanosponges for Topical Ocular Drug Delivery.
Hayiyana Z; Choonara YE; Makgotloe A; du Toit LC; Kumar P; Pillay V
Curr Pharm Des; 2016; 22(46):6988-6997. PubMed ID: 27981908
[TBL] [Abstract][Full Text] [Related]
9. Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study.
Ansari KA; Vavia PR; Trotta F; Cavalli R
AAPS PharmSciTech; 2011 Mar; 12(1):279-86. PubMed ID: 21240574
[TBL] [Abstract][Full Text] [Related]
10. The effect of complexation with cyclodextrins on the antioxidant and antimicrobial activity of ellagic acid.
Savic IM; Jocic E; Nikolic VD; Popsavin MM; Rakic SJ; Savic-Gajic IM
Pharm Dev Technol; 2019 Apr; 24(4):410-418. PubMed ID: 30035651
[TBL] [Abstract][Full Text] [Related]
11. Carboxylate cross-linked cyclodextrin: A nanoporous scaffold for enhancement of rosuvastatin oral bioavailability.
Gabr MM; Mortada SM; Sallam MA
Eur J Pharm Sci; 2018 Jan; 111():1-12. PubMed ID: 28931488
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of Bioavailability of Non-nucleoside Reverse Transciptase Inhibitor Using Nanosponges.
Rao MRP; Shirsath C
AAPS PharmSciTech; 2017 Jul; 18(5):1728-1738. PubMed ID: 27757921
[TBL] [Abstract][Full Text] [Related]
13. Improving the solubility and in vitro cytotoxicity (anticancer activity) of ferulic acid by loading it into cyclodextrin nanosponges.
Rezaei A; Varshosaz J; Fesharaki M; Farhang A; Jafari SM
Int J Nanomedicine; 2019; 14():4589-4599. PubMed ID: 31296988
[No Abstract] [Full Text] [Related]
14. Physical formulation approaches for improving aqueous solubility and bioavailability of ellagic acid: A review.
Nyamba I; Lechanteur A; Semdé R; Evrard B
Eur J Pharm Biopharm; 2021 Feb; 159():198-210. PubMed ID: 33197529
[TBL] [Abstract][Full Text] [Related]
15. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB).
Arulmozhi V; Pandian K; Mirunalini S
Colloids Surf B Biointerfaces; 2013 Oct; 110():313-20. PubMed ID: 23732810
[TBL] [Abstract][Full Text] [Related]
16. Solubility and dissolution rate enhancement of ibuprofen by cyclodextrin based carbonate nanosponges.
Shoaib QU; Latif S; Ijaz QA; Afzal H; Siddique MI; Hussain A; Arshad MS; Bukhari NI; Abbas N
Pak J Pharm Sci; 2021 May; 34(3(Supplementary)):1045-1055. PubMed ID: 34602431
[TBL] [Abstract][Full Text] [Related]
17. Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical characterization, stability and cytotoxicity.
Swaminathan S; Pastero L; Serpe L; Trotta F; Vavia P; Aquilano D; Trotta M; Zara G; Cavalli R
Eur J Pharm Biopharm; 2010 Feb; 74(2):193-201. PubMed ID: 19900544
[TBL] [Abstract][Full Text] [Related]
18. Sono-assembly of ellagic acid into nanostructures significantly enhances aqueous solubility and bioavailability.
Gu W; Kong R; Qi S; Cheng X; Cai X; Zhou Z; Zhang S; Zhao H; Song J; Hu Q; Yu H; Tong H; Wang Y; Lu T
Food Chem; 2024 Jun; 442():138485. PubMed ID: 38278106
[TBL] [Abstract][Full Text] [Related]
19. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
Sawant KK; Patel MH; Patel K
Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of solubility, photostability and antioxidant activity of ellagic acid cyclodextrin nanosponges fabricated by melt method and microwave-assisted synthesis.
Sharma K; Kadian V; Kumar A; Mahant S; Rao R
J Food Sci Technol; 2022 Mar; 59(3):898-908. PubMed ID: 35153320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
